Drug intelligence / Profile preview

Jiangbai Weiyan Pian

Development stage
Unknown
Lead developer
Huadong Medicine
Modality
Small Molecules
Administration
Oral
01

Overview

Jiangbai Weiyan Pian is a Traditional Chinese Medicine (TCM) tablet developed by Hangzhou Huadong Medicine Group Bioengineering Research Institute. It is classified as a Category 1.1 innovative Chinese medicine, a designation for new formulations with significant clinical value. The drug is primarily indicated for the treatment of chronic non-atrophic gastritis, specifically targeting patients with the 'spleen and stomach damp-heat' syndrome according to TCM diagnostic criteria. The formulation is composed of herbal extracts, including *Dalbergia odorifera* (Jiangxiang) and *Phellodendron amurense* (Huangbai). Pharmacologically, it is designed to clear heat, resolve dampness, and alleviate pain. Its therapeutic effects are attributed to anti-inflammatory activity and the protection of the gastric mucosal barrier, which helps reduce symptoms such as epigastric pain, bloating, and acid reflux. As of recent clinical reports, the drug is in Phase 3 development in China.

Brand names
Jiangbai Weiyan Pian
Other names
降柏胃炎片
02

Targets

TNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)

Beyond the preview

Go deeper on Jiangbai Weiyan Pian.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiangbai Weiyan Pian.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call